Skip to main content

Aurinia Pharmaceuticals Inc 10-Q for FY2025 Q3

Aurinia Pharmaceuticals Inc. (AUPH)

10-Q 2025-11-04 For: 2025-09-30
View Original
Added on April 04, 2026

About this 10-Q

Aurinia Pharmaceuticals Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$73.47M
up 8.4% from $67.77M a year earlier
Net income
$31.55M
up 119.9% from net income of $14.35M a year earlier
Diluted EPS
$0.23
up 130.0% from $0.10 a year earlier